Risk factors for drug resistance in pulmonary tuberculosis inpatients

Journal of Evidence-Based Medicine

Volumn 3, Issue 3, 2010, Pages 162-167

  Yang, Xiaoyan ^a   Li, Youping ^a   Wen, Xianmin ^b   Wu, Guihui ^b   Li, Xi ^b  

^a SICHUAN UNIVERSITY   (China)

^b Chengdu Tuberculosis Hospital   (China)

Author keywords

Drug resistance; logistic regression; multidrug resistant tuberculosis (MDR TB); pulmonary tuberculosis; risk factors

Indexed keywords

ADULT; AGRICULTURAL WORKER; ARTICLE; DRUG RESISTANCE; FEMALE; HOSPITAL PATIENT; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL STAFF; PRIORITY JOURNAL; RISK FACTOR; WORK ENVIRONMENT;

ADULT; ANTITUBERCULAR AGENTS; CHINA; DRUG RESISTANCE, MICROBIAL; FEMALE; HUMANS; INPATIENTS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TUBERCULOSIS, PULMONARY;

EID: 78449302206     PISSN: 17565383     EISSN: 17565391     Source Type: Journal    
DOI: 10.1111/j.1756-5391.2010.01088.x     Document Type: Article

References (13)

1. Yang XY, Zhang NM, Diao X, Mao X, Li YP,. Epidemiological analysis of pulmonary tuberculosis in Sichuan Province, China, 2000-2006. International Journal of Infectious Diseases 2008; 12 (5): 534-41.
2. Yang XY, Li YP, Mei YW, Yu Y, Xiao J, Luo J, et al. Time and spatial distribution of multidrug-resistant tuberculosis among Chinese people, 1981-2006: a systematic review (in press). International Journal of Infectious Diseases 2010; doi: 10.1016/j.ijid.2010.02.2244.
3. Liu Y, Duan W, Xiong G, Wu J, Cao H, Xia L, et al. The dynamic change of drug resistance of tuberculosis in Sichuan Province, Journal of Preventive Medicine 2002; 18 (1): 9-10.
4. Sichuan Provincial Office of Epidemiological Survey for Tuberculosis. Report on Epidemiology Survey of Tuberculosis in Sichuan Province in 2000. Compilation of information on TB control in Sichuan Province 1991-2002.
5. Chinese Anti-tuberculosis Association. The laboratory science procedure of diagnostic bacteriology in tuberculosis. Chinese Journal of Antituberculosis 1996; 18 (1): 28-31.
6. Ridzon R, Whitney CG, McKenna MT, Taylor JP, Ashkar SH, Nitta AT, et al. Risk factors for Rifampin mono-resistant tuberculosis. American Journal of Respiratory and Critical Care Medicine 1998; 157 (6 Pt 1): 1881-4.
7. WHO. Treatment of tuberculosis: guidelines for national programmes. 3rd Edition. WHO/CDS/TB/2003.313.
8. WHO. Report of the meeting of the WHO Global Task Force on XDR-TB. WHO/HTM/TB/2007.375.
9. Natal S, Valente JG, Sánchez AR, Penna ML,. Isoniazid and rifampicin resistance and prior treatment for tuberculosis. Cadernos de Saädeg;de Pädeg;blica 2003; 19 (5): 1277-81.
10. Yang BF, Xu B, Jiang WL, Zhou PY, Jiang QW,. Study on the epidemiology and determinants of drug-resistant tuberculosis in Northern rural area of Jiangsu province. Zhonghua Liu Xing Bing Xue Za Zhi 2004; 25 (7): 582-5.
11. Choi JC, Lim SY, Suh GY, Chung MP, Kim H, Kwon OJ, et al. Drug resistance rates of Mycobacterium tuberculosis at a private referral center in Korea. Journal of Korean Medical Science 2007; 22 (4): 677-81.
12. Baliza M, Bach AH, Queiroz GL, Melo IC, Carneiro MM, Albuquerque Mde F, et al. High frequency of resistance to the drugs isoniazid and rifampicin among tuberculosis cases in the City of Cabo de Santo Agostinho, an urban area in Northeastern Brazil. Revista da Sociedade Brasileira de Medicina Tropical 2008; 41 (1): 11-6.
13. Story A, Murad S, Roberts W, Verheyen M, Hayward AC,; London Tuberculosis Nurses Network. Tuberculosis in London: the importance of homelessness, problem drug use and prison. Thorax 2007; 62 (8): 667-71.